Johnson & Johnson
JNJ
$157.94
Share price
-0.24%
Change (1 day)
-10.46%
Change (1 year)
Categories
Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.
Johnson & Johnson (JNJ) - Total assets
Total assets on the balance sheet as of December 2022 : $187.37 B
According to Johnson & Johnson's latest financial reports the company's total assets are $187.37 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Johnson & Johnson - Total assets on balance sheet (from 2001 to 2022)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $187.37 B | 2.94% |
| 2021-12-31 | $182.01 B | 4.07% |
| 2020-12-31 | $174.89 B | 10.88% |
| 2019-12-31 | $157.72 B | 3.12% |
| 2018-12-31 | $152.95 B | -2.76% |
| 2017-12-31 | $157.30 B | 11.4% |
| 2016-12-31 | $141.20 B | 5.84% |
| 2015-12-31 | $133.41 B | 1.75% |
| 2014-12-31 | $131.11 B | -1.18% |
| 2013-12-31 | $132.68 B | 9.34% |
| 2012-12-31 | $121.34 B | 6.78% |
| 2011-12-31 | $113.64 B | 10.43% |
| 2010-12-31 | $102.90 B | 8.69% |
| 2009-12-31 | $94.68 B | 11.51% |
| 2008-12-31 | $84.91 B | 4.89% |
| 2007-12-31 | $80.95 B | 14.74% |
| 2006-12-31 | $70.55 B | 21.6% |
| 2005-12-31 | $58.02 B | 8.83% |
| 2004-12-31 | $53.31 B | 10.47% |
| 2003-12-31 | $48.26 B | 19% |
| 2002-12-31 | $40.55 B | 5.37% |
| 2001-12-31 | $38.48 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $112.24 B | -40.10% | 🇨🇭 Switzerland |
 Pfizer PFE | $197.20 B | 5.24% | 🇺🇸 USA |
 Abbott Laboratories ABT | $74.43 B | -60.27% | 🇺🇸 USA |
 Medtronic MDT | $94.13 B | -49.76% | 🇮🇪 Ireland |
 Eli Lilly LLY | $53.16 B | -71.63% | 🇺🇸 USA |
 Sanofi SNY | $135.71 B | -27.57% | 🇫🇷 France |
 Gilead Sciences GILD | $61.87 B | -66.98% | 🇺🇸 USA |
 Stryker Corporation SYK | $36.83 B | -80.34% | 🇺🇸 USA |
 Merck MRK | $109.16 B | -41.74% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $72.58 B | -61.26% | 🇬🇧 UK |